Transaction · 0002114309-26-000007

Xu Cong Claire

Xu Cong Claire, EVP, CD, reported a transaction classified as exercise at NovaBridge Biosciences involving 9382.000000 shares. Reported holdings after the transaction were 307483.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CD
NBPNovaBridge Biosciences
Trade date
Aug 30, 2026
Filing date
Sep 01, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded9.38kPrice unknown
Holdings after307kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

NBP price since this filing

Daily closing prices, with the filing date and available return windows
NBP · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0002114309-26-000007
Ordinary Shares
Transaction date
Aug 30, 2026
Filed Sep 01, 2026, 10:00 PM · 2d delay
Shares
9,382 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
307,483 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+2 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Clinical Development

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.

  2. F2

    Reported securities are represented by 4,079 ADSs.

  3. F3

    Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.

  4. F4

    Reported securities are represented by 133,688 ADSs.

  5. F5

    Reported securities are represented by 1,427 ADSs.

  6. F6

    Reported sales price represents the converted sales price of the ADSs of $1.8186.

  7. F7

    Reported securities are represented by 132,261 ADSs.

  8. F8

    Reported securities represent ADSs.

  9. F9

    On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting…

Original filing · 0002114309-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

NBP